Bristol Myers Squibb

Diversifying Clinical Trials: A Global Initiative With Local Roots

Article

Increasing diversity in clinical trials (DiCT) is imperative to improve the health of populations around the world. Everyone has the right to achieve optimal health outcomes — that’s the core of what health equity means. Without including representative populations in clinical trials, diverse groups are unable to participate in the development of critical, often life-saving, therapies — exacerbating inequities and creating new ones.

The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to Be Trained

52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative
Press Release

PRINCETON, N.J., October 22, 2021 /3BL Media/ - The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced th

OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum

Multimedia with summary

Saliendo! Our OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum featuring BristolMyersSquibb employees reflecting on their coming out journeys within Hispanic & LatinX communities.

Celebrating the Science That Transforms Patients' Lives

Article

By Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development

Team BMS Moves for Minutes to Benefit Special Olympics

$1 million donation to Special Olympics supports mission of building a more inclusive world
Article

Bristol Myers Squibb will donate $1 million to Special Olympics as part of the company’s global workforce charity event, BMS for Community. During the event, employees, their families and patients came together to move for minutes in any way that felt most comfortable, with the goal of supporting Special Olympics in its efforts to build a world celebrating people of all abilities.

And there was no shortage of minutes moved.

Bristol Myers Squibb and Five Leading Historically Black Colleges and Universities Launch Tomorrow's Innovators to Create Custom Biopharma Educational Programming and Increase Recruitment of Black Talent in the Biopharma Industry

Summary: 
  • Florida A&M University, Howard University, Morgan State University, North Carolina A&T University and University of Arkansas at Pine Bluff will pioneer the program in collaboration with Bristol Myers Squibb.
  • Tomorrow’s Innovators hopes to create actionable change within the biopharma industry by improving the recruitment and retention of diverse talent and enhancing the student educational experience at participating Historically Black Colleges and Universities (HBCUs).
Press Release
  • Florida A&M University, Howard University, Morgan State University, North Carolina A&T University and University of Arkansas at Pine Bluff will pioneer the program in collaboration with Bristol Myers Squibb.
  • Tomorrow’s Innovators hopes to create actionable change within the biopharma industry by improving the recruitment and retention of diverse talent and enhancing the student educational experience at participating Historically Black Colleges and Universities (HBCUs).

Expert Panel Issues Recommendations for Addressing Inequities in Cancer Care

Article

New recommendations published by Doykos et al in Health Equity call for a significant expansion of the National Cancer Institute (NCI) and NCI-designated comprehensive cancer centers to understand the causes of inequities in cancer care and a commitment to building sustained community partnerships to reduce them.

The Bristol Myers Squibb Foundation Announces First Global Cancer Disparities Grants in Brazil

Four projects in Brazil receive inaugural grants to improve delivery of care for lung cancer and melanoma patients
Press Release

NEW YORK, May 25, 2021 /3BL Media/ - The Bristol Myers Squibb Foundation has launched a new initiative in Brazil, awarding four grants aimed at improving the delivery of high-quality care for lung cancer and skin cancer to medically underserved and rural communities. The organizations that have received grants are focused on community outreach and disease education, strengthening collaborations among primary care physicians and oncologists, and supporting efforts to promote early diagnosis and treatment.

Subscribe to Bristol Myers Squibb